In this week’s View, Dr. Eagle explores a study looking at the long-term safety and efficacy of the subcutaneous implantable cardioverter-defibrillator system. He then explores combination lipid-lowering therapy in patients undergoing PCI versus statin therapy alone. Finally, Dr. Eagle looks at an important article on raced-based differences in the management of ST segment elevation myocardial infarction. 

Subscribe to Eagle’s Eye View